CD8A and neoplasm: Previous studies have demonstrated that RHDV VLP conjugated to tumour lysates are cross-presented by human DC to induce strong CD8+ T-cell responses in vitro, although, murine DC have shown no evidence of activation by VLP (Win et al, 2011).